<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="other"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Indian J Endocrinol Metab</journal-id><journal-id journal-id-type="iso-abbrev">Indian J Endocrinol Metab</journal-id><journal-id journal-id-type="publisher-id">IJEM</journal-id><journal-title-group><journal-title>Indian Journal of Endocrinology and Metabolism</journal-title></journal-title-group><issn pub-type="ppub">2230-8210</issn><issn pub-type="epub">2230-9500</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">22701848</article-id><article-id pub-id-type="pmc">3354927</article-id><article-id pub-id-type="publisher-id">IJEM-16-63</article-id><article-id pub-id-type="doi">10.4103/2230-8210.94262</article-id><article-categories><subj-group subj-group-type="heading"><subject>Brief Communication</subject></subj-group></article-categories><title-group><article-title>Metformin and sleep disorders</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wiwanitkit</surname><given-names>Somsri</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Wiwanitkit</surname><given-names>Viroj</given-names></name><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1"><italic>Wiwanitkit House, Bangkhae, Bangkok, Thailand</italic></aff><author-notes><corresp id="cor1"><bold>Corresponding Author:</bold> Mrs. Somsri Wiwanitkit, Wiwanitkit House, Bangkhae, Bangkok 10160, Thailand. E-mail: <email xlink:href="somsriwiwan@hotmail.com">somsriwiwan@hotmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>3</month><year>2012</year></pub-date><volume>16</volume><issue>Suppl1</issue><fpage>S63</fpage><lpage>S64</lpage><permissions><copyright-statement>Copyright: &#x000a9; Indian Journal of Endocrinology and Metabolism</copyright-statement><copyright-year>2012</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Metformin is a widely used anti-diabetic drug. Deterioration of sleep is an important unwanted side effect of metformin. Here, the authors review and present the details on metformin and sleep problem.</p></abstract><kwd-group><kwd>Metformin</kwd><kwd>sleep disorders</kwd><kwd>side effect</kwd></kwd-group></article-meta></front><body><sec id="sec1-1"><title>I<sc>NTRODUCTION</sc></title><p>Diabetes mellitus is a common endocrine disorder. Millions of patients have to use anti-diabetic drugs. A widely used oral anti-diabetic drug is metformin (C<sub>4</sub>H<sub>11</sub>N<sub>5</sub> &#x000b7; HCl). Under fasting conditions, about 50 % bioavailability of metformin has been observed.[<xref ref-type="bibr" rid="ref1">1</xref>] After ingestion, metformin is slowly absorbed and reaches its peak level in blood in 1-3 hours, and its elimination half-life is about 1.5-6 hours.[<xref ref-type="bibr" rid="ref1">1</xref>] The main route of metformin elimination is tubular secretion.[<xref ref-type="bibr" rid="ref1">1</xref>] Metformin use results in decreased hepatic glucose production and decreased intestinal absorption of glucose.[<xref ref-type="bibr" rid="ref1">1</xref>] In addition, metformin can help improve insulin sensitivity via increasing peripheral glucose uptake and utilization.[<xref ref-type="bibr" rid="ref1">1</xref>]</p><p>Similar to other drugs, adverse effects of metformin are reported. These can result in poor compliance of the diabetic patient,[<xref ref-type="bibr" rid="ref1">1</xref>] causing an irregular intake of the drug.[<xref ref-type="bibr" rid="ref1">1</xref>] Apart from the well known ill effects of hypoglycemia and diarrhea, other unwanted effects of metformin have also been observed. The effect of metformin on sleep is interesting. Here, the authors review and present the details on metformin and sleep problem.</p></sec><sec id="sec1-2"><title>M<sc>ETFORMIN</sc> &#x02013; I<sc>NDUCED</sc> I<sc>NSOMNIA</sc></title><p>Metformin &#x02013; induced insomnia is widely mentioned in old and obese diabetic patients who have been diagnosed with diabetes mellitus recently and prescribed with metformin. The development of insomnia can be seen within a few days after starting metformin. This is an interesting unwanted effect that is not quoted in other antidiabetic drugs. In a web report (<ext-link ext-link-type="uri" xlink:href="www.eheathme.com">www.eheathme.com</ext-link>), about 1.4% of people who observed side-effects when taking metformin had insomnia.[<xref ref-type="bibr" rid="ref2">2</xref>] There are some arguments whether metformin is the causative substance leading to insomnia. Diabetic patients are normally prone to insomnia.[<xref ref-type="bibr" rid="ref3">3</xref>] Blood glucose levels are related to the duration of sleep , and change in blood glucose levels after starting with metformin might be a possible mechanism by which metformin induces insomnia.[<xref ref-type="bibr" rid="ref4">4</xref>] In addition, the co-morbidity, diabetes mellitus with depression is a common condition, and this too can result in insomnia.[<xref ref-type="bibr" rid="ref5">5</xref>] The defect of the endocannabinoid system, which is a drug target, in diabetes mellitus can be a possible pathogenesis of metformin-induced insomnia.[<xref ref-type="bibr" rid="ref6">6</xref>]</p></sec><sec id="sec1-3"><title>M<sc>ETFORMIN AND</sc> D<sc>REAMS</sc></title><p>As already discussed, metformin can result in sleep disturbance, and this might affect normal dream patterns. Nightmares are reported in patients receiving metformin.[<xref ref-type="bibr" rid="ref7">7</xref>] However, they are less frequent than insomnia.[<xref ref-type="bibr" rid="ref8">8</xref>] Indeed, the cerebral blood glucose is known for its relationship to dreaming[<xref ref-type="bibr" rid="ref9">9</xref><xref ref-type="bibr" rid="ref10">10</xref>] and the change of its level after intake of metformin might be the underlying pathogenesis of nightmares.</p></sec><sec id="sec1-4"><title>M<sc>ETFORMIN AND</sc> S<sc>LEEP</sc> A<sc>PNEA</sc></title><p>There are many reports on relationship between diabetes and sleep apnea. In contrast, metformin is proven for its preventive ability for sleep apnea.[<xref ref-type="bibr" rid="ref11">11</xref><xref ref-type="bibr" rid="ref12">12</xref>] Since metformin is useful for management of diabetes cases with metabolic syndrome, which is a risk factor for sleep apnea,[<xref ref-type="bibr" rid="ref13">13</xref><xref ref-type="bibr" rid="ref14">14</xref>] hence, metformin is helpful for preventing sleep apnea. In animal model studies, it is reported that &#x0201c;Metformin is an efficient curative and preventive treatment for sleep apnea, suggesting that insulin resistance modifies the ventilatory drive independently of obesity.&#x0201d;[<xref ref-type="bibr" rid="ref11">11</xref>]</p></sec><sec id="sec1-5"><title>M<sc>ETFORMIN AND</sc> S<sc>LEEPWALKING</sc></title><p>This topic is little mentioned. Although this problem is extremely rare, it has been reported.[<xref ref-type="bibr" rid="ref15">15</xref>] Nevertheless, there is no proposed pathological mechanism of sleepwalking in a patient receiving metformin. However, in a hyperthyroid patient, there is a report on the sleepwalking due to the defect in the endocrine pathway.[<xref ref-type="bibr" rid="ref16">16</xref>]</p></sec><sec sec-type="conclusion" id="sec1-6"><title>C<sc>ONCLUSION</sc></title><p>There are many reports that metformin can result in some sleep problems, especially insomnia. On the other hand, metformin is proven to be useful for preventing sleep apnea. The exact relationship between metformin and sleep problems is still not clear, and further studies for a more clear understanding are warranted.</p></sec></body><back><fn-group><fn fn-type="supported-by"><p><bold>Source of Support:</bold> Nil,</p></fn><fn fn-type="conflict"><p><bold>Conflict of Interest:</bold> None declared.</p></fn></fn-group><ref-list><title>R<sc>EFERENCES</sc></title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouchoucha</surname><given-names>M</given-names></name><name><surname>Uzzan</surname><given-names>B</given-names></name><name><surname>Cohen</surname><given-names>R</given-names></name></person-group><article-title>Metformin and digestive disorders</article-title><source>Diabetes Metab</source><year>2011</year><volume>37</volume><fpage>90</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">21236717</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="webpage"><article-title>Metformin and insomnia</article-title><date-in-citation>Last accessed on 2011 Jun 1</date-in-citation><comment>Available from:
<uri xlink:type="simple" xlink:href="http://www.ehealthme.com/ds/metformin/insomnia+concerns">http://www.ehealthme.com/ds/metformin/insomnia+concerns</uri></comment></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosekind</surname><given-names>MR</given-names></name><name><surname>Gregory</surname><given-names>KB</given-names></name></person-group><article-title>Insomnia risks and costs: Health, safety, and quality of life</article-title><source>Am J Manag Care</source><year>2010</year><volume>16</volume><fpage>617</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">20712395</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakajima</surname><given-names>H</given-names></name><name><surname>Kaneita</surname><given-names>Y</given-names></name><name><surname>Yokoyama</surname><given-names>E</given-names></name><name><surname>Harano</surname><given-names>S</given-names></name><name><surname>Tamaki</surname><given-names>T</given-names></name><name><surname>Ibuka</surname><given-names>E</given-names></name><etal/></person-group><article-title>Association between sleep duration and hemoglobin A1c level</article-title><source>Sleep Med</source><year>2008</year><volume>9</volume><fpage>745</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">17921062</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodnick</surname><given-names>PJ</given-names></name></person-group><article-title>Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy</article-title><source>Ann Clin Psychiatry</source><year>2001</year><volume>13</volume><fpage>31</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">11465683</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheen</surname><given-names>AJ</given-names></name></person-group><article-title>The endocannabinoid system: A promising target for the management of type 2 diabetes</article-title><source>Curr Protein Pept Sci</source><year>2009</year><volume>10</volume><fpage>56</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">19275673</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avery</surname><given-names>JK</given-names></name></person-group><article-title>A therapeutic nightmare</article-title><source>Tenn Med</source><year>2000</year><volume>93</volume><fpage>415</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">11077888</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="webpage"><article-title>Nightmare</article-title><date-in-citation>Last accessed on 2011 Jun 1</date-in-citation><comment>Available from:
<uri xlink:type="simple" xlink:href="http://www.ehealthme.com/sa/3105465/nightmare">http://www.ehealthme.com/sa/3105465/nightmare</uri></comment></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gottschalk</surname><given-names>LA</given-names></name><name><surname>Buchsbaum</surname><given-names>MS</given-names></name><name><surname>Gillin</surname><given-names>JC</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Reynolds</surname><given-names>CA</given-names></name><name><surname>Herrera</surname><given-names>DB</given-names></name></person-group><article-title>Positron-emission tomographic studies of the relationship of cerebral glucose metabolism and the magnitude of anxiety and hostility experienced during dreaming and waking</article-title><source>J Neuropsychiatry Clin Neurosci</source><year>1991</year><volume>3</volume><fpage>131</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">1821226</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heiss</surname><given-names>WD</given-names></name><name><surname>Pawlik</surname><given-names>G</given-names></name><name><surname>Herholz</surname><given-names>K</given-names></name><name><surname>Wagner</surname><given-names>R</given-names></name><name><surname>Wienhard</surname><given-names>K</given-names></name></person-group><article-title>Regional cerebral glucose metabolism in man during wakefulness, sleep, and dreaming</article-title><source>Brain Res</source><year>1985</year><volume>327</volume><fpage>362</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">3872693</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramadan</surname><given-names>W</given-names></name><name><surname>Dewasmes</surname><given-names>G</given-names></name><name><surname>Petitjean</surname><given-names>M</given-names></name><name><surname>Wiernsperger</surname><given-names>N</given-names></name><name><surname>Delanaud</surname><given-names>S</given-names></name><name><surname>Geloen</surname><given-names>A</given-names></name><etal/></person-group><article-title>Sleep apnea is induced by a high-fat diet and reversed and prevented by metformin in non-obese rats</article-title><source>Obesity (Silver Spring)</source><year>2007</year><volume>15</volume><fpage>1409</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">17557978</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramadan</surname><given-names>W</given-names></name><name><surname>Petitjean</surname><given-names>M</given-names></name><name><surname>Loos</surname><given-names>N</given-names></name><name><surname>Geloen</surname><given-names>A</given-names></name><name><surname>Vardon</surname><given-names>G</given-names></name><name><surname>Delanaud</surname><given-names>S</given-names></name><etal/></person-group><article-title>Effect of high-fat diet and metformin treatment on ventilation and sleep apnea in non-obese rats</article-title><source>Respir Physiol Neurobiol</source><year>2006</year><volume>150</volume><fpage>52</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">16448934</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin-Du</surname><given-names>Pan RC</given-names></name><name><surname>Ruiz</surname><given-names>J</given-names></name></person-group><article-title>Metabolic syndrome: Jumble syndrome of obesity or specific entity.Which treatment: Diet or Polypill?</article-title><source>Rev Med Suisse</source><year>2008</year><volume>4</volume><fpage>366</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">18386674</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aylwin</surname><given-names>S</given-names></name><name><surname>Al-Zaman</surname><given-names>Y</given-names></name></person-group><article-title>Emerging concepts in the medical and surgical treatment of obesity</article-title><source>Front Horm Res</source><year>2008</year><volume>36</volume><fpage>229</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">18230906</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="webpage"><article-title>Sleepwalking</article-title><date-in-citation>Last accessed on 2011 Jun 1</date-in-citation><comment>Available from:
<uri xlink:type="simple" xlink:href="http://www.ehealthme.com/ds/metformin/sleep+walking">http://www.ehealthme.com/ds/metformin/sleep+walking</uri></comment></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ajlouni</surname><given-names>KM</given-names></name><name><surname>Ahmad</surname><given-names>AT</given-names></name><name><surname>El-Zaheri</surname><given-names>MM</given-names></name><name><surname>Ammari</surname><given-names>FL</given-names></name><name><surname>Jarrah</surname><given-names>NS</given-names></name><name><surname>Abujbara</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Sleepwalking associated with hyperthyroidism</article-title><source>Endocr Pract</source><year>2005</year><volume>11</volume><fpage>5</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">16033729</pub-id></element-citation></ref></ref-list></back></article>